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Background: Emerging evidence suggests that vitamin D might be implicated in asthma pathophysiology. This
study aims to compare Vitamin D mean serum levels and status between asthmatic and non-asthmatic adolescents
and investigate the association of vitamin D with asthma severity.
Methods: In a cohort of adolescents aged 16–17 years, those reporting wheezing in the past 12 months and Ever
asthma on the ISAAC questionnaire were invited to participate and formed the Active Asthmatics group. Controls
were selected amongst Never Wheezers/Never Asthmatics (NWNA). Differences in mean 25(OH)D serum levels and
vitamin D status between AA and NWNA were examined in multivariate linear and logistic regression models
respectively, adjusting for potential confounders. Within AA, differences in vitamin D levels were assessed across
asthma severity indicators.
Results: A total of 69 AA and 671 NWNA participated in the study. Unadjusted mean 25(OH)D serum levels were
22.90 (SD 6.41), and 21.15 (SD 5.59) ng/mL in NWNA and AA respectively (p = 0.03). In adjusted models, mean
25(OH)D levels remained significantly lower amongst AA compared to NWNA (adjusted beta coefficient −1.68, 95%
CI −3.24, −0.13). Severe (<12 ng/mL), moderate (<25 ng/mL) or insufficient (<30 ng/mL) vitamin D status was more
prevalent among AA who were 1.6 times (95% CI 1.01, 2.53) more likely to belong to a lower vitamin D category
compared to NWNA. Within AA, there was a negative trend between vitamin D levels and the number of reported
asthma severity indicators.
Conclusions: Levels of vitamin D tend to be lower among asthmatic compared to non-asthmatic children and in
those with severe asthma independent of important confounders.
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In the last decades, vitamin D deficiency has reappeared
as a major public health problem worldwide affecting
people of all ages, even in regions with abundant sun
exposure [1-3]. Over the same period, the prevalence of
asthma and allergies has been also increasing [4]. This
has been mainly attributed to changes in environmental* Correspondence: kolokotroni.o@unic.ac.cy
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unless otherwise stated.and lifestyle factors such as the reduced exposure to
infections, dietary changes and obesity [5]. There is now
an increasing body of evidence suggesting that vitamin
D may have multiple biological effects, beyond bone
metabolism, including the pathogenesis of respiratory
and allergic diseases [6,7].
Recently, a fast rising number of studies have looked
into a possible association between asthma and inad-
equate levels of vitamin D but evidence is still conflicting
[8-18]. Some cross-sectional studies have shown serum
vitamin D levels to be lower in asthmatic compared to
healthy children [9,10,12,13] but others did not observe
significant differences [11,14,15]. Even within the smallntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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conflicting. For example, Van Oeffelen et al. found higher
vitamin D levels at the age of four to be associated with re-
duced risk of asthma at the age of eight whilst Tolpannen
et al. showed that higher 25(OH)D3 levels at the age of 10
are associated with increased risk of incident asthma and
wheezing in the following year [16,17]. Additionally, there
also seems to be limited and inconsistent findings regard-
ing the role of vitamin D in the development of other
allergic conditions [19,20].
A number of these studies were limited by their small
sample sizes, the wide age range of study participants and
differences in the definition of asthma [9,11,13,14]. Further-
more, a large number of studies reported only univariate
comparisons of mean vitamin D levels between asthmatics
and non-asthmatics [8,11,14], some matched cases and
control for gender and/or ethnicity [9,10,12] but only few
studies considered important confounders such as adipos-
ity, sun exposure and season of testing [13,16]. Higher
adiposity levels, lower sun exposure, winter season, female
gender and darker skin types have been shown to be associ-
ated with lower vitamin D levels in healthy individuals due
to their effect on vitamin D production and/or bioavailabil-
ity [21,22]. Some of these factors such as obesity have been
also shown to be more prevalent in asthmatic children [23].
Differences in these factors between asthmatic and non-
asthmatic children can therefore obscure any true differ-
ences in vitamin D levels amongst the two groups.
Despite the so far controversial evidence on the associ-
ation of vitamin D with asthma in the general population,
findings from a small number of studies amongst asth-
matics have shown an inverse relationship between suffi-
cient vitamin D levels and asthma severity indicators such
as the use of asthma medication [24,25], asthma exacerba-
tions and hospitalisation in asthmatic children [8]. This
could be suggestive of an important role of vitamin D in
asthma development and/or management which needs
further assessment.
The aim of this descriptive comparative population-
based study was to compare mean vitamin D levels as well
as the prevalence of hypovitaminosis between asthmatic
and non-asthmatic adolescents in Cyprus, a country with
rising childhood asthma and obesity [26,27] and investi-
gate whether potential differences can be explained by the
confounding effect of variables that relate to vitamin D
production or bioavailability. Furthermore this study also




Participants were selected from a cohort of 5384 ado-
lescents aged 16–17 years who had completed the
International Study of Asthma and Allergies inChildhood (ISAAC) questionnaire as part of a large
school-based study on risk factors for asthma. All subjects
who reported having wheezing in the past 12 months and
ever asthma were invited to participate in the study and
formed the active asthmatics (AA) group. Controls were
selected amongst those adolescents who did not report
either wheezing or asthma ever (Never Wheezers Never
Asthmatics - NWNA). In line with the scope of another
study on the relation of adiposity with asthma, NWNA
had been selected using a stratified random sampling
approach in order to increase the probability of selection
of children at the extremes of BMI change between child-
hood and adolescence.
Assessments
Participants attended the paediatric department of their
nearest local hospital in the three main districts of the is-
land (Nicosia, Limassol and Larnaca) between November
2007 and May 2008 and underwent blood sampling,
anthropometric measurements and questionnaire assess-
ments of physical activity levels, dietary intake of vitamin
D and sun exposure as described previously [22].
In brief, Serum levels of 25-hydroxy-vitamin D were
assessed using the enzyme immune assay kit of Immuno-
diagnostics Systems Ltd, UK (intra- and inter-assay coeffi-
cients of variation < 12%). Anthropometric measurements
were taken in the morning with the subjects dressed in
light clothing and without shoes. Body fat percent was
measured with the use of a portable Body Mass Compos-
ition Analyser (TBF-300 Body composition Analyzer,
Tanita Corporation, USA). The International Physical
Activity Questionnaire (IPAQ) was employed in order to
evaluate levels of physical activity and the data collected
were analysed as per IPAQ guidelines [28]. Dietary Food
Intake was assessed with the use of a Food Frequency
Recall questionnaire (FFQ) which recorded the frequency
of consumption of food items from 21 food categories
over the preceding three months. Dietary intake of vita-
min D was calculated based on the questionnaire data
using local food-composition tables adapted to the Greek
cuisine [29]. Sun exposure was reported by participants as
time spent in the sun during weekends and holidays in the
winter and in the summer months of the past 3 years re-
corded as hours per day in increments of 1 to a maximum
of 4 hours per day [30]. In addition, the children’s habitual
use of sun protection (use of sun block creams, clothing,
hats) when out in the sun in the summer was recorded as
never/rarely, occasionally, most of the time, and always/al-
most always. Furthermore, trained research assistants clas-
sified the child’s skin type as dark, olive, olive/medium,
medium/fair and fair. Parental education as a proxy for
socio-economic status (the highest level of educational
attainment by either of the two parents), Current smoking
status and Family history of allergies (father, mother,
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also recorded. Finally the following asthma severity indica-
tors were reported, based on the corresponding questions
of the ECHRS questionnaire: Have you ever visited the
Emergency department because you had difficulty with
your breathing? (Emergency room visit), Have you ever
been admitted to hospital with breathing problems, even
for one night? (Hospital Admission), Have you had an
asthma attack in the last 12 months? (Asthma attacks in
the last 12 months), Are you currently on any medication
for your asthma such as inhalers, liquid suspensions or
oral tablets? (Asthma medication use). The study was ap-
proved by the Cyprus National Bioethics Committee and
written informed consent was obtained from the children
and their parents or guardians.
Statistical analysis
Linear regression models were used to investigate (a) the
association of 25(OH)D levels with a number of possible
determinants within each study group and (b) differences
in mean serum levels of 25(OH)D between the study
groups before and after adjusting for potential con-
founders. Initial power calculations showed that the sam-
ple size had >90% power to detect a two-tail statistically
significant result at the 5% level for 0.5 SD and 0.35 SD
difference respectively (i.e. moderate to small) in vitamin
D levels between the two comparison groups. Further-
more, odds ratios of inadequate vitamin D status between
Active Asthmatics (AA) and the Non asthmatic group
(NWNA) were estimated in binary logistic regression
models where hypovitaminosis status was categorised as
(a) severe deficiency (serum 25-(OH)D <12 ng/mL), (b)
deficiency (<20 ng/mL) and (c) moderate Deficiency
(<25 ng/mL) (d) insufficiency (<30 ng/mL). After ensuring
that the proportional odds assumption holds, ordinal lo-
gistic regression analysis was used to estimate the propor-
tional odds ratios across ordered vitamin D status
categories. This provides a summary estimate and avoids
the need to use estimates from different models to de-
scribe the relationship at each level of hypovitaminosis.
Multivariable linear and logistic models adjusted for gen-
der, body fat percent, self-reported sun exposure in winter,
skin type and season of blood sampling since these were
identified as important predictors for vitamin D levels in
the NWNA group. While typically the annual seasonal
variation of vitamin D levels displays a sinusoidal pattern,
during our study which only spanned from November
until May, this corresponded to a U-shape pattern which
was similar in both cases and controls and, hence season-
ality was controlled for by using a quadratic function i.e.
month +month2. In all analyses, we applied normalised
sampling weights based on inverse probability of selection
of NWNA from the original population. Statistical analysis
was performed using the statistical software PASW 18.Results
A total of 69 AA and 671 NWNA participated in the study
with 63% and 72% response rates respectively of the popu-
lations that were targeted for recruitment. Baseline char-
acteristics of participants in each group are presented in
Table 1. The mean age of participants (of whom 1 in 4
were male) was 17 (SD 0.6) years. The study groups did
not differ significantly in most characteristics including
age, gender, parental education level, physical activity
levels, dietary intake of vitamin D, use of sun protection
or skin type. Interestingly, controls reported lower levels
of sun exposure both during the summer as well as winter
and AA reported higher frequency of current smoking
despite differences not reaching statistical significance.
Specifically, only 17.4% of the NWNA reported exposure
to the sun for more than 3 hours per day during holidays
and weekends in the winter as opposed to 24.6% of the
AA whilst the frequency of current smoking was 15.9% in
AA as compared to 9.8% in NWNA (Table 1). As expected
reporting of a positive family history of allergies was sig-
nificantly higher in AA as compared to NWNA (49.3% vs
19.4%, p = 0.00). Finally a higher proportion of NWNA
had their vitamin D levels measured during the winter
season as compared to AA and CWO.
Levels of 25(OH)D appeared to be normally distributed
in the study populations whilst mean values were generally
low in both groups (Table 2). With a mean of 21.15 ng/ml
(SD 5.59), levels were lower among AA as compared to
22.90 ng/ml (SD 6.41) in NWNA. Among the control
group, female gender, season of blood testing, lower sun
exposure in winter, darker skin type and higher body fat
percent were significantly associated with lower vitamin D
levels (Table 2). In fact, a similar pattern was observed
within AA, which however did not always reach signifi-
cance at the 5% level.
Differences in mean 25(OH)D levels and Vitamin D
status between the two groups are presented in Table 3.
AA had significantly lower mean 25(OH)D levels when
compared to NWNA (adjusted b coefficient −1.67, 95%
CI −3.20, −0.14, p = 0.03). The observed differences were
small (in the order of 2–3 ng/ml) but remained statistically
significant even after adjusting for gender, season of testing,
body fat percent, sun exposure and skin type in multivari-
able linear regression models.
Overall, as many as 1 in 3 participants were vitamin D
deficient (i.e. levels <20 ng/ml) whilst the prevalence of
vitamin D insufficiency (i.e. <30 ng/ml) exceeded 80%.
Generally higher prevalence of inadequate vitamin D status
was observed among AA compared to non-asthmatics,
although differences were statistically significant only with
regards to moderate deficiency (<25 ng/ml) and insuffi-
ciency (<30 ng/ml ). AA were 3-times more likely to have
25(OH)D levels lower than 30 ng/ml (OR 3.45, 95% CI
1.06, 11.22) and 2-times more likely to have 25(OH)D







n = 671 n = 69
Gender: Male 42.8% 43.5% 0.91
Season of assessments




None/Primary 3.0% 7.2% 0.14
Secondary 61.9% 55.1%
Tertiary 35.2% 37.7%
Sun exposure in the Summer
< 1 hour/day 2.8% 4.3% 0.22
1-2 hours/day 15.8% 7.2%
2-3 hours/day 25.9% 23.2%
3-4 hours/day 24.8% 24.6%
>4 hours/day 30.6% 40.6%
Sun exposure in the Winter
< 1 hour/day 21.6% 15.9% 0.55
1-2 hours/day 39.2% 39.1%
2-3 hours/day 21.9% 20.3%
3-4 hours/day 11.4% 17.4%
>4 hours/day 6.0% 7.2%
Sun protection









Olive 4.0% 2.9% 0.97
Olive medium 69.5% 69.6%
Medium fair 25.0% 26.1%
Fair 1.5% 1.4%
Exercise level (IPAQ)
Low 52.9% 49.2% 0.40
Moderate 34.0% 41.5%
High 13.1% 9.2%
Dietary intake vitamin D




Current smokers 9.8% 15.9% 0.11
Table 1 Participant characteristics by study group
(Continued)
Age – Mean (SD)
in years)
17.0 (0.61) 16.9 (0.57) 0.63
Body fat percent
– Mean (SD)
22.0 (8.9) 21.7(8.6) 0.77
†Notes: p-value of t-test in the case of age and body fat percent; otherwise,
p-value of chi-square test.
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After adjusting for factors that may confound the observed
associations, there was generally not much attenuation
in the estimates even though the odds ratio estimate
remained statistically significant only for moderate vita-
min D deficiency (OR 1.91, 95% CI 1.05, 3.49). Further-
more, using an ordinal logistic regression model to
provide a summery estimate of the odds ratio across or-
dered categories of decreasing 25(OH)D levels (i.e. < 12,
< 20, < 25, < 30 ng/ml), AA appeared to be 1.6- times
(95% CI 1.01, 2.53) more likely to belong to a lower sta-
tus of vitamin D compared to NWNA (p-value for test
of the proportionality assumption in the ordinal logistic
model = 0.67).
Finally, in Table 4, differences in vitamin D levels across
asthma severity indicators in the AA group are presented.
In general, participants reporting positively to any of the
asthma severity questions had lower, albeit not always sig-
nificant, levels of vitamin D. More specifically, children
reporting having at least one asthma attack in the last
12 months and ever needing to use the emergency depart-
ment for breathing difficulties had significantly lower vita-
min D levels by 3–4 units as compared to those that
responded negatively to these questions (b coefficient
−3.05, 95% CI −6.07, −0.04 and b coefficient −3.76, 95%
CI −6.74, −0.79). Similarly, lower levels of vitamin D,
albeit of lower magnitude and not significant were
noted in children reporting asthma medication use and
ever needing a hospital admission for breathing prob-
lems (b coefficient −1.80, 95% CI - 4.82, 1.22 and b co-
efficient −2.40, 95% CI −6.13, 1.34). More importantly,
a linear negative trend between vitamin D levels and
the number of reported asthma severity indicators was
noted. Specifically, for every one additional positive re-
sponse to the asthma severity questions there was a sig-
nificant decrease in vitamin D levels (b coefficient −1.55,
95% CI −2.78, −0.33).
Discussion
In this study, there was evidence to suggest that active
asthmatics have generally lower 25(OH)D levels and are
more likely to belong to a lower vitamin D status category
across the range of 25(OH)D values, which appears to be
independent of factors that relate to the production or
Table 2 Differences in mean 25(OH)D by participant characteristics in the two study groups (NWNA and AA) separately
Never Wheezers Never Asthmatics (NWNA) Active Asthmatics (AA)
n = 671 n = 69
Variable Mean 25(OH)D levels (SD) p-value† Mean 25(OH)D levels (SD) p-value†
Gender Male 23.87 (6.62) <0.01 21.70 (5.20) 0.48
Female 22.23 (6.19) 20.71 (5.92)
Season Autumn 25.86 (6.73) 0.03 26.80 (2.55) 0.49
Winter 22.73 (6.51) 20.91 (5.43)
Spring 22.61 (6.10) 21.01 (5.72)
Sun exposure in Summer <1 hour 22.05 (6.05) 0.25 16.33 (6.23) 0.09
1-2 hours 22.58 (7.13) 21.08 (8.45)
2-3 hours 22.57 (6.25) 19.78 (5.97)
3-4 hours 23.07 (5.88) 21.94 (4.47)
>4 hours 23.22 (6.63) 22.00 (5.34)
Sun exposure in Winter <1 hour 22.16 (6.62) <0.01 17.63 (6.18) 0.18
1-2 hours 22.31 (6.06) 22.34 (5.100
2-3 hours 23.69 (6.67) 20.01 (5.53)
3-4 hours 23.98 (5.83) 22.68 (6.12)
>4 hours 25.13 (7.52) 22.18 (3.20)
Use of sun protection Never/rarely 22.75 (6.10) 0.36 20.49 (6.99) 0.94
Occasionally 22.88 (6.88) 22.11 (4.42)
Most of the time 22.16 (5.79) 18.69 (5.14)
Almost always/Always 23.93 (6.54) 21.73 (6.08)
Skin type Olive 23.42 (8.84) 0.04 23.95 (0.78) 0.01
Olive/Medium 22.48 (6.23) 22.15 (5.00)
Medium/Fair 23.83 (6.59) 18.47 (6.55)
Fair 24.30 (5.37) 16.30 (0)
Exercise level (IPAQ) Low 22.75 (6.57) 0.40 21.13 (6.14) 0.81
Moderate 22.88 (6.23) 21.06 (5.25)
High 23.47 (6.07) 22.05 (5.27)
Parental education Elementary 22.68 (7.44) 0.62 22.20 (3.05) 0.87
Secondary 22.99 (6.50) 20.80 (5.38)
Tertiary 22.65 (6.16) 21.48 (6.28)
Smoking status No 22.86 (6.75) 0.06 21.27 (5.68) 0.69
Yes 24.54 (6.83) 20.52 (5.36)
Body fat percent Quartile 1 23.48 (6.30) 0.02 22.23 (5.68) 0.33
Quartile 2 23.42 (7.08) 21.45 (4.66)
Quartile 3 23.07 (5.91) 20.72 96.17)
Quartile 4 21.78 (6.23) 20.38 (6.08)
Dietary intake vitamin D <400 IU 22.96 (6.43) 0.13 20.87 (5.59) 0.14
>400.1 IU 21.27 (5.77) 24.90 (6.83)
Notes: †With the exception of gender and dietary vitamin D intake where p-value for difference is reported, in all other cases, p-value for linear trend is reported.
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lower vitamin D levels were associated with asthma sever-
ity indicators such as asthma attack in the last 12 months
and emergency room visit for breathing problems. Of noteis the very high proportion of asthmatics with vitamin D
deficiency and insufficiency in our study, even against a
background of a generally high prevalence of vitamin D
deficiency in Cyprus. This is however comparable
Table 3 Differences in mean vitamin D levels and prevalence of inadequate vitamin D status between asthmatic and
non-asthmatic participants
Mean (SD) Unadjusted Model† Adjusted Model*
b coefficient (95% CI) b coefficient (95% CI)
Vitamin D levels NWNA 22.90 (6.41) Ref Ref
AA 21.15 (5.59) −1.76 (−3.34 , −0.17); p = 0.03 −1.67 (−3.20, −0.14); p = 0.03
Prevalence (%) Unadjusted Model‡ Adjusted Model*
OR (95% CI) OR (95% CI)
Severe vitamin D deficiency NWNA 4.0% Ref Ref
(levels < 12 ng/mL) AA 8.7% 2.32 (0.92, 5.84); p = 0.08 2.54 (0.97, 6.62); p = 0.06
Vitamin D deficiency NWNA 34.7% Ref Ref
(levels <20 ng/mL) AA 40.6% 1.26 (0.76, 2.10); p = 0.37 1.21 (0.72, 2.04); p = 0.47
Moderate vitamin D deficiency NWNA 61.6% Ref Ref
(levels <25 ng/mL) AA 75.4% 1.88 (1.05, 3.37); p = 0.03 1.91 (1.05, 3.49); p = 0.04
Vitamin D insufficiency NWNA 84.0% Ref Ref
(levels < 30 ng/mL) AA 94.2% 3.45 (1.06, 11.22); p = 0.04 3.23 (0.98, 10.65); p = 0.05
Odds of belonging to a lower category of vitamin D levels# NWNA Ref Ref
AA 1.60 (1.01, 2.51); p = 0.04 1.60 (1.01, 2.53); p = 0.04
p value for proportionality assumption in the ordinal model p = 0.509 p = 0.656
Notes: †b coefficients corresponds to difference in mean vitamin D levels between Active Asthmatics (AA) and the Non asthmatic group (NWNA) as estimated in
linear regression models before and after adjusting for potential confounders ‡ Odds ratios of inadequate vitamin D status between AA and NWNA as estimated
in logistic regression models before and after adjusting for potential confounders *Multiple linear and logistic regression models adjusted for gender, body fat
percent, season of assessment, self-reported sun exposure in winter, skin type. #Estimated in ordinal logistic regression models along with p-value of test for
parallel lines; a non-significant value provides evidence that the proportionality assumption of the ordinal model holds.
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gion as also seen in the study by Chinelato et al. in
Italy [11].
There are a number of limitations. The cross-sectional
design of the study does not permit any causal inference
with regards to the role of vitamin D in the development
of asthma. Nevertheless, unlike a number of previous
published studies, we were able to examine and adjust
for the effects of a number of factors that could poten-
tially confound the observed differences in vitamin D
levels between asthmatics and non-asthmatics. Even
though there was not much attenuation in the fully ad-
justed estimates, we cannot exclude the presence of re-
sidual confounding nor the fact that some of the
confounding variables were measured with the use of
self-reported questionnaires (e.g. sun exposure). Thus,
while exposure misclassification is possible, there is no
reason to suspect that this should be differential between
the comparison groups.
Evidence from this study suggesting that active asth-
matics have significantly lower 25(OH)D and a more com-
promised vitamin D status compared to non-asthmatic
children comes to add to the somewhat conflicting evi-
dence that has so far come from previous studies on this
topic [8-15]. Nonetheless, our findings seem to be more
consistent with those from previous studies that also con-
sidered potential confounders either at the design oranalysis stage [9,10,12,13]. For example, two studies from
the Middle East showed significant differences in mean
vitamin D levels between asthmatic and non-asthmatic
children matched by gender [9] and ethnicity [10,12].
Similarly in the study by Freishtat et al. from Washington
DC, USA median vitamin D levels were significantly lower
in children with physician diagnosis of asthma compared
to non-asthmatic controls, whilst the prevalence of vita-
min D deficiency and insufficiency was significantly higher
in asthmatics even after adjusting for age, sex, BMI and
season of sampling [13]. In contrast, the studies that didn’t
find any evidence of differences in vitamin D levels be-
tween asthmatics and controls [11,15], or even showed
that vitamin D levels were higher amongst asthmatics
than healthy controls [8], tend to provide only univariate
comparisons.
Indeed, differences in the distribution of predictors of
vitamin D levels amongst asthmatic and non-asthmatic
children might exaggerate or mask a true difference in
vitamin D concentrations between the two groups. Obes-
ity for example has been shown to be more prevalent be-
tween asthmatics [23,31] but also associated with lower
levels of vitamin D due to its sequestration in body fat
stores [32]. Similarly, asthma and vitamin D deficiency are
both more prevalent in female adolescents as opposed to
male [21,33]. Tolppanen et al. [16] In this study, however,
we showed that the observed differences in vitamin D
Table 4 Difference in Vitamin D levels by asthma severity indicators in active asthmatics
Asthma severity indicators Vitamin D Difference in mean Vitamin D levels between negative and
positive responseMean levels
Ng/mL (SD) (Reference Group: Negative)§
n = 69± b coefficient (95% CI); p value
Model 1* Model 2*
Asthma attacks in the last 12 months
No 59.4% 21.58 (5.54) −3.10 −3.05
Yes 40.6% 19.41 (5.40) (−5.80, −0.41); p = 0.03 (−6.07, −0.04); p = 0.05
Asthma medication use
No 62.3% 21.38 (5.31) −2.00 −1.80
Yes 37.7% 19.35 (5.78) (−4.92, 0.92); p = 0.18 (−4.82, 1.22); p = 0.24
Hospital admission
No 82.2% 21.07 (5.28) −2.90 −2.40
Yes 18.8% 18.52 (6.45) (−6.18, 0.67); p = 0.11 (−6.13, 1.34); p = 0.20
Emergency room visit
No 65.2% 21.77 (5.04) −3.43 −3.76
Yes 34.8% 18.72 (5.89) (−6.18, −0.67); p = 0.02 (−6.74, −0.79); p = 0.01
Asthma severity index
No Positive Answers 29.5% 22.62 (4.84) −1.51† −1.55†
1 Positive Answer 26.2% 21.13 (5.57) (−2.64, −0.37); p = 0.01 (−2.78, −0.33); p = 0.01
2 Positive Answers 23.0% 19.75 (5.28)
3 Positive Answers 16.4% 18.50 (6.18)
4 Positive Answers 4.9% 16.43 (6.58)
Notes: §b coefficients correspond to difference in mean vitamin D levels as estimated in linear regression models. *Model 1adjusted for seasonality. Model 2
further adjusting for gender, family history of Allergies, body fat %, smoking status and parental education. ±Missing data ranged from 0–8. †Change in mean
vitamin D levels per 1 unit change in asthma severity index (i.e. across increasing categories of severity).
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children appear to be independent of differences in con-
founders such as gender, body fat percent, sun exposure
in winter, skin type and season of blood sampling between
the groups. In fact, further adjusting for other potentially
important predictors of vitamin D levels, such as diet or
physical activity, does not alter this pattern.
Nevertheless, at about 2 ng/mL, the magnitude of the
observed difference in average levels of 25(OH)D between
asthmatics and non- asthmatics in our study appears to be
small, and thus, one could question its clinical significance.
On the other hand, we showed that differences in the vita-
min D status, as defined by cut off levels used for bone me-
tabolism are much larger in magnitude. Irrespective of the
cut-off point used, active asthmatics appeared up to 1.6
times more likely to belong to a lower vitamin D category.
Furthermore, active asthmatics appeared 2 to 3-times more
likely to have 25(OH)D levels under 30 ng/ml (insuffi-
ciency) as well as 12 ng/ml (severe deficiency) compared to
non-asthmatic adolescents, while this difference was less
evident in terms of vitamin D deficiency (i.e. 20 ng/ml). In
general, the study had 80% power to detect an association
in the magnitude of OR > 2. Since low levels of vitamin Dwere generally observed even among children in the con-
trol group (i.e. large concentrations of participants around
values of 20–25 ng/ml), a larger sample would have been
required to detect a statistically significant difference be-
tween the observed 41% Vs 35% in the prevalence of vita-
min D deficiency in AA and NWNA respectively.
Nevertheless, the magnitude of the observed prevalence
difference was much larger and thus statistically significant
at other critical values of the vitamin D range.
Furthermore, the results of this study showed that
reporting of asthma severity indicators and specifically
“having an asthma attack in the last 12 months” or “at-
tending the emergency department with breathing diffi-
culties” were associated with significantly lower vitamin
D levels. These findings are consistent with most previ-
ous published studies which have shown fewer asthma
exacerbations and lower utilisation of health care facil-
ities for urgent treatment in asthmatic children with
higher vitamin D levels [8,9,24,34]. Lower vitamin D
levels have also been shown to be associated with higher
asthma medication use and/or hospital admission for
asthma [24,25]. The association of vitamin D with these
indicators, despite not reaching statistical significance in
Kolokotroni et al. BMC Public Health  (2015) 15:48 Page 8 of 9our study has also been shown to be in the same
direction.
A number of biological explanations have been pro-
posed for the role of vitamin D in asthma pathogenesis.
Vitamin D, through its receptors on immune cells, has
been shown to promote the activities of innate immunity
whilst suppressing those of adaptive immunity, and thus
protecting from microbial invasion whilst down regulat-
ing lung inflammation [35]. Furthermore vitamin D has
been implicated in cell differentiation and airway remod-
elling through its receptors on epithelial cells lining the
respiratory tract and bronchial smooth muscle cells [36].
These mechanisms could potentially explain how indi-
viduals with lower vitamin D levels might be at higher
risk of developing asthma or having a more severe form
of the disease [6]. On the other hand it is possible that
asthma and vitamin D deficiency share the same genetic
loci resulting in merely the co-existence of the two con-
ditions in affected individuals as in the case of different
variants of vitamin D receptors on immune cells or cells
of the respiratory tract of asthmatics compared to non-
asthmatic individuals [36,37].
Conclusions
This study has showed that asthmatic children have
lower mean vitamin D levels and an increased likelihood
of belonging to an inadequate vitamin D status, which
does not seem to be explained by differences in behav-
ioural or other factors implicated either in vitamin D
production or bioavailability. Furthermore, that lower
vitamin D levels are associated with the presence of
asthma severity indicators. There is still much need for
more longitudinal studies to investigate the effects of
vitamin D deficiency on asthma development and sever-
ity as well as a better understanding of the biological
mechanisms behind this association. Furthermore, inter-
ventional studies looking at the potential beneficial ef-
fects of vitamin D supplementation will shed more light
on the reversibility of the vitamin D- asthma relationship
and consequently on the causal association of vitamin D
with asthma.
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